John W. Childs, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 700,000 shares at $31.23 ($22.1M) on 2020-04-06, disclosed to the SEC on 2020-04-08.
Open-market sale of $22.1M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.23 | 144,659 | $4.5M | 20.4% |
| 2 | $31.23 | 144,659 | $4.5M | 20.4% |
| 3 | $31.76 | 5,341 | $170K | 0.8% |
| 4 | $31.76 | 5,341 | $170K | 0.8% |
| 5 | $30.54 | 81,090 | $2.5M | 11.2% |
| 6 | $30.54 | 81,090 |
| $2.5M |
| 11.2% |
| 7 | $31.55 | 10,908 | $344K | 1.6% |
| 8 | $31.55 | 10,908 | $344K | 1.6% |
| 9 | $32.92 | 93,268 | $3.1M | 13.9% |
| 10 | $32.92 | 93,268 | $3.1M | 13.9% |
| 11 | $33.26 | 14,734 | $490K | 2.2% |
| 12 | $33.26 | 14,734 | $490K | 2.2% |
| Total | $31.62 avg | 700,000 | $22.1M | 100% |
| Filing → |
| MANE | BUY | 2026-02-05 | $5.0M | — | Filing → |
| BHVN | BUY | 2025-11-17 | $50.0M | — | Filing → |
| BHVN | BUY | 2025-03-05 | $892K | — | Filing → |